Loading…
Orchid Island Capital, Inc.
🏹 Trader: 🎯 Near 52W High View all →
$813M
Market Cap
5.8
P/E
0.11
PEG
ROCE
15.6%
ROE
7.37
D/E
88.6%
OPM
-14.3%
% from 52W High
55
α RS
🔍 ORC is showing a notable setup because it's within 14.3% of its 52-week high and momentum_movers preset's Backtest win rate is 53.2% over 90 days. Net: Partial signal stack, not a recommendation. ? 52W High Backtest
Sources
14.3% from 52W high · Backtest win rate 53.2%
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for ORC including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

Orchid Island Capital, Inc., a specialty finance company, invests in residential mortgage-backed securities (RMBS) in the United States. The company’s RMBS is backed by single-family residential mortgage loans, referred to as Agency RMBS. Its portfolio comprises traditional pass-through Agency RMBS, such as mortgage pass through certificates and collateralized mortgage obligations; and structured Agency RMBS, including interest only securities, inverse interest only securities, and principal only securities. The company has elected to be taxed as a real estate investment trust (REIT) for the United States federal income tax purposes. As a result, it would not be subject to corporate income tax on that portion of its net income that is distributed to stockholders, if it annually distributes dividends equal to at least 90% of its REIT taxable income to its shareholders. Orchid Island Capital, Inc. was incorporated in 2010 and is headquartered in Vero Beach, Florida.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
⭐ Superinvestors Holding ORC
View All Superinvestors →
Manager Shares Value % of Fund Period
Steve Cohen Point72 Asset Management 901.9K $6.3M 0.01% Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
📊 MIXED ORC reports Q1 net loss of $0.11 per share; book value $7.08
Revenue & Profitability
For Q1 2026, Orchid Island Capital reported a net loss of $0.11 per share compared to net income of $0.62 in Q4 2025. Book value per share stood at $7.08 at March 31, 2026, down from $7.54 at December 31, 2025. Dividends of $0.36 per share were declared in both quarters. Total return for Q1 was negative 1.3% versus positive 7.8% in the prior quarter.
Outlook
Management expressed a bullish outlook on the agency MBS market, citing stable interest rates, low implied volatility, benign funding conditions, and attractive returns (modeled 15%–17% return on equity). They noted that the largest tail risk from the war (massive escalation, damage to Middle East production) appears lower. However, they acknowledged uncertainty around the war's impact on growth and inflation.
Growth Drivers
Not discussed in this earnings call.
Balance Sheet & CapEx
Not discussed in this earnings call.
Margins
The company's expense ratio (G&A load) improved from just under 3% to 1.7% over the last year, driven by portfolio growth. Management expects this trend to continue as the company scales. No specific margin or net interest spread guidance was provided.
Key Risks
Management identified the ongoing war as a key risk with uncertain effects on growth and inflation. Prepayment speeds (which increased to 16.3 CPR in March) and interest rate volatility are also monitored. Analysts raised questions about dividend coverage and potential cuts due to taxable income dynamics.
Generated by AI · Q1 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q2 2026 Q2 2026 2026-07-24
Q2 saw a return to profitability with higher book value and total return, despite a dividend cut and increased expense ratio from one-time compensation. Portfolio positioning was fine-tuned amid rising market uncertainty, with leverage and hedge coverage both increasing.
Q1 2026 Q1 2026 2026-04-24
Q1 2026 saw a net loss and lower book value, but portfolio size and capital deployment increased. Market conditions remain favorable, with modeled ROE at 15%-17% and improved funding, though geopolitical risks persist.
Q4 2025 Q4 2025 2026-01-30
Q4 2025 net income rose to $103.4 million, with book value and total return both increasing. The portfolio doubled in size over the year, shifting to higher coupon, call-protected MBS, while expense ratios fell and funding costs improved.
Q3 2025 Q3 2025 2025-10-24
Q3 saw a return to profitability with net income of $0.53 per share and a 6.7% total return, driven by strategic deployment of $152 million in equity into high-coupon, call-protected agency MBS. The portfolio remains defensively positioned with strong liquidity and low rate sensitivity.
Q2 2025 Q2 2025 2025-07-25
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.